Clinical Management of Suspected or Confirmed COVID-19 Disease Version 4 (18 May 2020)

Clinical Management of Suspected or Confirmed COVID-19 Disease Version 4 (18 May 2020)

Clinical Management of Suspected or Confirmed COVID-19 Disease Version 4 (18 May 2020)

These guidelines describe the clinical management of cases of COVID-19 disease and covers clinical care in and outside health care facilities. It is intended for health care practitioners taking care of symptomatic patients with suspected or confirmed COVID-19. These guidelines cover the case definitions, screening and diagnosis and clinical management of suspected and confirmed COVID-19 patients. The scope includes all levels of care from ambulatory patients seen in primary care and for screening purposes and symptomatic patients managed in health facilities, including intensive care units.

What's new in this version:

  • Updated case definition for a suspected COVID-19 case (section 3.1)
  • New guidance on SARS-CoV-2 sampling and on repeat testing (section 3.2)
  • Recommendation against the use of rapid antibody-based tests for the routine diagnosis of acute COVID-19 (section 3.2)
  • Removal of the requirement that mild disease in high-risk individuals requires hospitalization (section 4.1)
  • Guidance on patients requiring nebulized medications or inhaled or systemic steroid use for management of their comorbidities (section 4.2)
  • Updates to critical care section (section 4.5) Specific guidance on children, HIV patients, and pregnant/breastfeeding women (section 5)
  • Updated guidance on the forms required when testing and managing COVID-19 patients (section 7)
Type
Guides/Guidelines
Topic
Communicable Diseases
Language
English
Publisher
National Department of Health
Year
2020
Author
National Department of Health